IRIS
DICHIARA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.998
NA - Nord America 1.206
EU - Europa 1.122
SA - Sud America 454
AF - Africa 51
OC - Oceania 1
Totale 4.832
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.156
SG - Singapore 602
RU - Federazione Russa 466
CN - Cina 452
BR - Brasile 369
IT - Italia 324
VN - Vietnam 274
HK - Hong Kong 213
KR - Corea 164
IN - India 74
FR - Francia 57
JP - Giappone 50
GB - Regno Unito 41
DE - Germania 38
FI - Finlandia 32
AR - Argentina 31
NL - Olanda 31
TW - Taiwan 31
IE - Irlanda 24
MX - Messico 23
BD - Bangladesh 22
AT - Austria 19
CA - Canada 19
ZA - Sudafrica 19
ID - Indonesia 18
IQ - Iraq 14
KE - Kenya 14
IR - Iran 12
UA - Ucraina 12
EC - Ecuador 11
ES - Italia 11
CO - Colombia 10
PL - Polonia 10
AE - Emirati Arabi Uniti 9
PH - Filippine 9
TR - Turchia 9
VE - Venezuela 8
CH - Svizzera 7
CL - Cile 7
PE - Perù 7
PK - Pakistan 7
LT - Lituania 6
PY - Paraguay 6
AL - Albania 4
AZ - Azerbaigian 4
BE - Belgio 4
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
KG - Kirghizistan 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
UZ - Uzbekistan 4
BY - Bielorussia 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
RS - Serbia 3
SE - Svezia 3
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
NI - Nicaragua 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
Totale 4.830
Salva come PNG Salva come JPEG
Città #
Dallas 403
Singapore 349
Hefei 226
Hong Kong 167
Seoul 154
Moscow 134
Santa Clara 107
Ho Chi Minh City 100
Beijing 81
Los Angeles 74
San Jose 64
Hanoi 63
Ashburn 54
Council Bluffs 51
Milan 48
Siena 48
Lauterbourg 43
Bengaluru 41
Tokyo 41
Florence 35
The Dalles 35
Chicago 26
São Paulo 26
Dublin 24
Rome 24
Buffalo 21
Taipei 18
Helsinki 17
Redondo Beach 16
Nuremberg 15
Catania 13
Haiphong 13
Lappeenranta 13
Vienna 13
Johannesburg 12
Orem 11
Salt Lake City 11
Tehran 11
Mexico City 10
Rio de Janeiro 10
Chennai 9
Da Nang 9
Frankfurt am Main 9
New York 9
Belo Horizonte 8
Lucca 8
Turin 8
Warsaw 8
Amsterdam 7
Baghdad 7
London 7
Montreal 7
Quito 7
Asunción 6
Biên Hòa 6
Bologna 6
Curitiba 6
Dobong-gu 6
Lima 6
Manaus 6
Phoenix 6
Phủ Lý 6
Cape Town 5
Denver 5
Dhaka 5
Hải Dương 5
Manchester 5
Nairobi 5
Piscataway 5
Poplar 5
Porto Alegre 5
Salvador 5
Santo André 5
Seattle 5
Zurich 5
Abidjan 4
Atlanta 4
Baku 4
Bishkek 4
Boardman 4
Bogotá 4
Brasília 4
Brescia 4
Brooklyn 4
Caivano 4
Campinas 4
Campo Grande 4
Caracas 4
Chai Wan 4
Columbus 4
Draper 4
Ha Kwai Chung 4
Hortolândia 4
Houston 4
Islamabad 4
Kwun Tong 4
Macaé 4
Manila 4
Messina 4
Mumbai 4
Totale 2.944
Salva come PNG Salva come JPEG
Nome #
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients 331
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds 303
Biostimulants for Sustainable Food Production: Effects of Wood Distillate to Fortify Chickpea Flour for Development of Functional Bakery Products 217
Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3 162
Discovery of p-Trifluoromethylbenzohydrazide Derivatives as Potent Antiviral Agents against Monkeypox Virus 147
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: design, synthesis, and pharmacological evaluation 141
Novel N-normetazocine derivatives with opioid Agonist/Sigma-1 receptor antagonist profile as potential analgesics in inflammatory pain 133
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 126
Structural and molecular insight into Piperazine and Piperidine derivatives as Histamine H3 and Sigma-1 receptor antagonists with promising antinociceptive properties 118
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 117
Cytotoxicity profiles and neuroprotective properties of the novel ifenprodil analogues as sigma ligands 113
Unlocking the potential of biostimulants in sustainable agriculture: Effect of wood distillate on the nutritional profiling of apples 109
Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors 107
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] derivatives as potent and selective sigma receptor ligands: stereochemistry and pharmacological properties 107
Tuning properties for blood-brain barrier permeation: a statistics-based analysis 105
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 105
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 104
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 103
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain 102
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity 102
Correction to “Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents” 101
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity 100
Designing drugs optimized for both blood–brain barrier permeation and intra-cerebral partition 100
Novel N-Substituted benzomorphan-based compounds: from MOR-agonist/DOR-antagonist to biased/unbiased MOR agonists 98
Discovery, affinity maturation and multimerization of small molecule ligands against human tyrosinase and tyrosinase-related protein 1 98
Nitric oxide photo-donor hybrids of ciprofloxacin and norfloxacin: a shift in activity from antimicrobial to anticancer agents 93
Synthesis, computational insights, and evaluation of novel sigma receptors ligands 92
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 92
Exploiting the power of stereochemistry in drug action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as potent Sigma-1 receptor antagonist 88
New Insights into the Opioid Analgesic Profile of cis-(−)-N-Normetazocine-derived Ligands 86
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 85
Structure–Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis 82
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches 79
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: preliminary studies as a potential multifunctional agent against uveal melanoma 78
Sigma-2 receptor ligands QSAR model dataset 76
Sigma receptor ligands carrying a nitric oxide donor nitrate moiety: synthesis, In silico, and biological evaluation 74
H2S releasing molecules in pharmaceutical development 73
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 71
Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5ʹ-monophosphate glycosidase 70
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 66
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents 66
Open Source Antibiotics: Simple Diarylimidazoles Are Potent against Methicillin-Resistant Staphylococcus aureus 66
Repurposing of human kinase inhibitors in neglected protozoan diseases 63
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors 50
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 50
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 46
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect 46
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 41
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 39
Totale 5.021
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.962
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202363 0 0 0 0 0 0 0 0 0 0 62 1
2023/2024159 1 0 0 5 0 3 18 2 5 0 18 107
2024/20251.403 39 27 130 45 138 120 39 61 191 79 95 439
2025/20263.396 255 511 510 582 506 96 454 129 130 223 0 0
Totale 5.021